La hemoglobina glicada como marcador del riesgo cardiovascular en adultos no diabéticos
Uno de los aspectos claves en el control de la enfermedad cardiovascular es conocer bien el riesgo asociado a la hiperglucemia que no es diagnóstica de diabetes. Por ello es importante este estudio que demuestra que la hemoglobina glicada es útil para este fin.
Leer texto completo: “La hemoglobina glicada como marcador del riesgo cardiovascular en adultos no diabéticos”
ArtÃculos de referencia:
1. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800-811.
2. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8.
3. DCCT Research Group: The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968 –983.
4. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1988;352:837–853.
5. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–1334.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:Suppl1:S62-S69.
Fuente: Suplemento Excelencia ClÃnica: Impacto. Mayo 2010;3(5). Actualidad.
